Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer

被引:0
|
作者
Jessie R. Nedrow
Joseph D. Latoche
Kathryn E. Day
Jalpa Modi
Tanushree Ganguly
Dexing Zeng
Brenda F. Kurland
Clifford E. Berkman
Carolyn J. Anderson
机构
[1] University of Pittsburgh,Department of Radiology
[2] University of Pittsburgh,Department of Pharmacology and Chemical Biology
[3] University of Pittsburgh,Department of Bioengineering
[4] University of Pittsburgh,Department of Biostatistics
[5] Washington State University,Department of Chemistry
来源
关键词
PSMA; PET; Copper-64; Phosphoramidate; Irreversible inhibitor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:402 / 410
页数:8
相关论文
共 47 条
  • [1] Targeting PSMA with a Cu-64 Labeled Phosphoramidate Inhibitor for PET/CT Imaging of Variant PSMA-Expressing Xenografts in Mouse Models of Prostate Cancer
    Nedrow, Jessie R.
    Latoche, Joseph D.
    Day, Kathryn E.
    Modi, Jalpa
    Ganguly, Tanushree
    Zeng, Dexing
    Kurland, Brenda F.
    Berkman, Clifford E.
    Anderson, Carolyn J.
    MOLECULAR IMAGING AND BIOLOGY, 2016, 18 (03) : 402 - 410
  • [2] Targeting PSMA with a 64Cu-labeled phosphoramidate inhibitor for PET/CT imaging of variant PSMA-expressing xenografts in a mouse model of prostate cancer
    Nedrow, Jessie
    Latoche, Joseph
    Day, Kathryn
    Ganguly, Tanushree
    Zeng, Dexing
    Berkman, Clifford
    Anderson, Carolyn
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [3] Cu-64 PSMA PET in Prostate Cancer
    Mirzaei, S.
    Grubmueller, B.
    Capasso, E.
    Knoll, P.
    Floth, A.
    Meleddu, C.
    Shariat, S.
    Klingler, H.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S675 - S675
  • [4] Clinical application of Cu-64 PSMA PET/CT in Theranostics of prostate cancer
    Singh, Aviral
    Kulkarni, Harshad
    Klette, Ingo
    Baum, Richard
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [5] Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer
    Sabina Sevcenco
    Hans Christoph Klingler
    Klaus Eredics
    Alexander Friedl
    Jenifer Schneeweiss
    Peter Knoll
    Thomas Kunit
    Lukas Lusuardi
    Siroos Mirzaei
    Advances in Therapy, 2018, 35 : 779 - 784
  • [6] Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer
    Sevcenco, Sabina
    Klingler, Hans Christoph
    Eredics, Klaus
    Friedl, Alexander
    Schneeweiss, Jenifer
    Knoll, Peter
    Kunit, Thomas
    Lusuardi, Lukas
    Mirzaei, Siroos
    ADVANCES IN THERAPY, 2018, 35 (06) : 779 - 784
  • [7] A high-affinity [18 F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer
    Ganguly, Tanushree
    Dannoon, Shorouk
    Hopkins, Mark R.
    Murphy, Stephanie
    Cahaya, Hendry
    Blecha, Joseph E.
    Jivan, Salma
    Drake, Christopher R.
    Barinka, Cyril
    Jones, Ella F.
    VanBrocklin, Henry F.
    Berkman, Clifford E.
    NUCLEAR MEDICINE AND BIOLOGY, 2015, 42 (10) : 780 - 787
  • [8] A high affinity 18F-labeled phosphoramidate peptidomimetic inhibitor as a PSMA-targeted PET imaging agent for prostate cancer
    Ganguly, Tanushree
    Dannoon, Shorouk
    Geruntho, Jonathan G.
    Hopkins, Mark R.
    Murphy, Stephanie Murphy
    Cahaya, Hendry
    Blecha, Joseph E.
    Jivan, Salma
    Cyril, Barinka
    Jones, Ella F.
    VanBrocklin, Henry F.
    Berkman, Clifford E.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S379 - S379
  • [9] 64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window
    Milot, Marie-Christine
    Benesty, Ophelie Belissant
    Dumulon-Perreault, Veronique
    Ait-Mohand, Samia
    Richard, Patrick O.
    Rousseau, Etienne
    Guerin, Brigitte
    PHARMACEUTICALS, 2022, 15 (08)
  • [10] 64Cu-PSMA-BCH: a new radiotracer for delayed PET imaging of prostate cancer
    Liu, Teli
    Liu, Chen
    Zhang, Zhongyi
    Zhang, Ning
    Guo, Xiaoyi
    Xia, Lei
    Jiang, Jinquan
    Xie, Qing
    Yan, Kun
    Rowe, Steven P.
    Zhu, Hua
    Yang, Zhi
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (13) : 4508 - 4516